Preoperative chemoradiation therapy for pancreatic cancer.
The authors present a critique of a fellow surgeon's version of multimodality therapy for patients with adenocarcinoma of the pancreas. Citing follow-up studies, the authors prescribe adjustments in therapeutic specifics to foster a more efficient approach to patients that results in lower toxicity and shorter treatment periods.
Evans
D B
DB
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston 77030-4095, USA.
Pisters
P W
PW
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D019583:Dose Fractionation, Radiation; D006801:Humans; D020360:Neoadjuvant Therapy; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D016577:Pancreaticoduodenectomy; D018714:Radiotherapy, Adjuvant